{"meta":{"id":"https:\/\/api.iclient.ifeng.com\/ipadtestdoc?aid=ucms_807s3dVboNP","type":"doc","o":"1","documentId":"ucms_807s3dVboNP"},"body":{"newStatus":"1","documentId":"ucms_807s3dVboNP","staticId":"ucms_807s3dVboNP","title":"华润医药:拟收购血制品巨头博雅生物控股权","shareTitle":"华润医药:拟收购血制品巨头博雅生物控股权","thumbnail_doc":"","thumbnail":"","source":"","author":"","editorcode":"weMedia","editTime":"2020-09-28 08:12:37","updateTime":"2020\/09\/28 08:12:37","wapurl":"http:\/\/\/\/feng.ifeng.com\/c\/807s3dVboNP","introduction":"","wwwurl":"http:\/\/\/\/feng.ifeng.com\/c\/807s3dVboNP","commentsUrl":"ucms_807s3dVboNP","commentCount":0,"text":"
9月28日周一,华润医药在港交所公告称,拟收购博雅生物制药集团控股权,建议收购事项条款须待进一步磋商后,方可作实。<\/p>
此前,博雅生物大股东老板被妻举报出轨致经营不善,公开信直指涉8亿预付款项目为重大并购失控。<\/p>","img":[],"summary":"9月28日周一,华润医药在港交所公告称,拟收购博雅生物制药集团控股权,建议收购事项条款须待进一步磋商后,方可作实。此前,博雅生物大股东老板被妻举报出轨致经营不善","sharesummary":"9月28日周一,华润医药在港交所公告称,拟收购博雅生物制药集团控股权,建议收购事项条款须待进一步磋商后,方可作实。此前,博雅生物大股东老板被妻举报出轨致经营不善","commentType":"0","wemediaEAccountId":"704","showclient":"0","shareurl":"https:\/\/ishare.ifeng.com\/c\/s\/v002AXo3WhsCskIoa2QNR5kf7ntkr--9WxsNC--2KV6MMa3i8__","praise":"0","like_num":"0"}}